Business & Regulation

Akili Interactive releases a new version of its ADHD treatment game for adults.

Humira biosimilars finally launch on the US market

More pharma stakeholders are launching lawsuits over the US government’s Inflation Reduction Act.

How do we prevent criminals from reusing primary packaging for counterfeit medicines? Labeling solutions and other creative concepts can help.

MSD describes drug price negotiation program as “sham” and “tantamount to extortion”

Misbranded drugs, unapproved drugs, and companies who don’t know that ophthalmic drugs should be manufactured in a sterile environment…

Amgen’s planned acquisition of Horizon Therapeutics has hit a bump in the road.

There are many players in pharmaceutical pricing, from drug manufacturers to PBMs and pharmacies. Who should take the lead?

Hall Gregg, Chief Portfolio Officer at the Pistoia Alliance, discusses the transformative power of collaboration, innovation, and diversification

What can science learn from patients, and how can patients benefit from being in control of their own health?